A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/57 (2006.01)
Patent
CA 2221601
Methods of treatment and prevention of diseases associated with release of neutrophil elastase and IL-8 by administration of TFPI, and analogs of TFPI are disclosed. Methods of determining efficacy of treatment with TFPI, patient's responsiveness to treatment with TFPI and the ultimate determination of patient prognosis are also disclosed.
L'invention concerne des procédés de traitement et de prévention des maladies associées à la libération de la neutrophile-élastase et de l'IL-8 par l'administration de l'inhibiteur de la voie du facteur tissulaire (TFPI) et d'analogues de celui-ci. Elle concerne également des procédés pour déterminer l'efficacité du traitement avec le TFPI, la réactivité du patient à un tel traitment et la détermination ultime du pronostic relatif au patient.
Aarden Lucien A.
Creasey Abla A.
Johnson Kirk
Borden Ladner Gervais Llp
Central Laboratory Of The Netherlands Red Cross Blood Transfusio
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Regulation of cytokine synthesis and release does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of cytokine synthesis and release, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of cytokine synthesis and release will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1571593